8 analysts have shared their evaluations of Health Catalyst (NASDAQ:HCAT) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table encapsulates their ...

Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Health Catalyst (NASDAQ:HCAT) in the last three months. In the table below, you'll find a ...

Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, ...

Health Catalyst’s third quarter results were met with a positive market reaction as the company delivered revenue above Wall Street expectations despite flat year-over-year performance. Management ...

CAMBRIDGE, England--(BUSINESS WIRE)--In a new whitepaper, ‘Exploring productivity in the age of Generative AI’, specialist technology provider Content Catalyst shares the top things that Analyst firms ...

The latest price target for Health Catalyst (NASDAQ:HCAT) was reported by Citigroup on November 11, 2025. The analyst firm set a price target for $3.25 expecting HCAT to rise to within 12 months (a ...